Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion type Assertion NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_head.
- NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion description "[Further aims were to compare karyotypic features of t-AML/t-MDS with de novo AML/MDS, in our material as well as in 5098 unselected, cyto- genetically abnormal, published cases, and to analyze associations between type of prior therapy and karyotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_provenance.
- NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion evidence source_evidence_literature NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_provenance.
- NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion SIO_000772 12454741 NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_provenance.
- NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion wasDerivedFrom befree-2016 NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_provenance.
- NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_assertion wasGeneratedBy ECO_0000203 NP375865.RAb1A3whYRbw2KYIMhrCUlVVU7AFI5ibEGUGfwyx26pXs130_provenance.